ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Pediatric"

  • 2017 American Transplant Congress

    Inflammation, Impaired Energy Metabolism and Synthetic Failure Characterize the Liver Transcriptome of End-Stage Idiopathic Pediatric Acute Liver Failure (PALF).

    M. Ningappa,1 P. McKiernan,2 R. Squires,2 Q. Sun,1 B. Higgs,1 K. Soltys,1 G. Bond,1 C. Ashokkumar,1 G. Mazariegos,1 R. Sindhi.1

    1Pediatric Abdominal Surgery, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA; 2Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA

    Background: PALF requiring liver transplantation (LTx) often has no known etiology, and could result from undiagnosed metabolic disorders. Mitochondrial dysfunction is common in PALF, but…
  • 2017 American Transplant Congress

    Kidney Size Does Not Matter: Should the Decision to Split Pediatric En Bloc Donor Kidneys Be Based on Donor Weight Rather Than Kidney Length?

    A. Perry, J. Woloszyn, J. McVicar, J. Sageshima, R. Perez, C. Troppmann, C. Santhanakrishnan.

    Division of Transplant Surgery, University of California, Davis, Sacramento, CA

    Background: Deceased donor kidneys from pediatric donors have been used with good results. However, there is little consensus on the criteria used to safely split…
  • 2017 American Transplant Congress

    Racial and Ethnic Disparities in Renal Replacement Therapy in Pediatric and Young Adult Population with End Stage Renal Disease (2005-2015).

    R. George,1 M. Basu,2 L. Greenbaum,1 A. Kirk,2,3 N. Kutner,4 R. Patzer.2,5

    1Pediatric Nephrology, Emory University, Atlanta, GA; 2Dept of Surgery, Emory University, Atlanta, GA; 3Dept of Surgery, Duke University, Durham, NC; 4USRDS Rehabilitation, QoL Special Studies Center, Atlanta, GA; 5Dept of Epidemiology, Rollins School of Public Health, Atlanta, GA

    In the last decade, few studies have examined racial/ethnic disparities in the choice of renal replacement therapy (RRT) among children with End Stage Renal Disease…
  • 2017 American Transplant Congress

    Primary Graft Dysfunction After Pediatric Heart Transplant.

    K. Mowers, K. Simpson, P. Eghtesady, O. Petrucci, C. Canter, C. Castleberry.

    Pediatric Cardiology, Washington University School of Medicine, St. Louis, MO

    Background: Primary graft dysfunction (PGD), as defined by ISHLT Consensus Guidelines, has been associated with worse outcomes in adult heart transplant recipients, even in patients…
  • 2017 American Transplant Congress

    Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.

    R. Hendrickson, M. Davis, A. Sherman, W. Andrews, J. Daniel, R. Fischer, D. Blowey.

    Transplant Surgery, Health Services and Outcomes Research, Hepatology, and Nephrology, Children's Mercy Hospital, Kansas City, MO

    BACKGROUND: Hypertension (HTN) occurs after solid organ transplant and may have an impact on future cardiovascular disease and associated co-morbidities. Little has been reported on…
  • 2017 American Transplant Congress

    Longer Ischemic Time Is Associated with Late Graft Dysfunction in Pediatric Heart Transplant Recipients.

    L. Schroeder,1 S. Chowdhury,1 A. Burnette,1 H. Baker,1 A. Savage,1 A. Atz,1 R. Butts.2

    1Medical University of South Carolina, Charleston, SC; 2UT Southwestern, Dallas, TX

    Introduction: The purpose of this study was to investigate associations between clinical factors and cardiac function as measured by pressure-volume loops (PVL) in a pediatric…
  • 2017 American Transplant Congress

    Pediatric Recipients of Deceased Adult Donor Kidneys Have Equivalent Outcomes Compared with Pediatric Donors.

    D. Mikhail,1 H. Sharma,3,4 J. Chen,2 M. Cooper,4 A. Sener,1,3 P. Luke.1,3

    1Urology, Western University, London, ON, Canada; 2Schulich School of Medicine and Dentistry, Western University, London, ON, Canada; 3Multi-Organ Transplant Surgery, Western University, London, ON, Canada; 4Transplant Surgery, Georgetown University, Washington, DC

    INTRODUCTION:Efforts are made to transplant paediatric deceased donor kidneys into pediatric recipients. To our knowledge, data does not support better graft outcomes with matched pediatric…
  • 2017 American Transplant Congress

    The TAKE-IT Intervention Improves Medication Adherence in Adolescent Kidney Transplant Recipients.

    B. Foster,1 A. Pai,2 S. Furth,3 TAKE-IT Investigators.

    1McGill University, Montreal, Canada; 2Cincinnati Children's Hospital Medical Center, Cincinnati; 3Children's Hospital of Philadelphia, Philadelphia

    Poor adherence to immunosuppressive medications limits renal allograft survival. This randomized controlled trial, evaluated whether young kidney transplant recipients administered a behavioral intervention showed greater…
  • 2017 American Transplant Congress

    A Pilot Test of the "Individualized Self-Management Training in Adolescent/Young Adult Recipients of Transplantation (iSTART)" Program.

    E. Fredericks, S. Eder, D. Egleston, W. Newhouse, D. O'Reilly, G. Freed, J. Magee, K. Resnicow.

    University of Michigan, Ann Arbor

    Objective: To pilot test the feasibility and impact of the iSTART program on medication adherence, quality of life, and medication barriers among adolescent/young adult (AYA)…
  • 2017 American Transplant Congress

    Alemtuzumab Use in a Single Center Pediatric Heart Transplant Cohort.

    J. Case,1 J. Eshelman,2 P. Booker,2 S. Miyamoto,3 M. Everitt,3 S. Auerbach.3

    1University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO; 2Pharmacy, Children's Hospital Colorado, Aurora, CO; 3Pediatrics, Division of Cardiology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO

    Purpose: To describe the use and complications of alemtuzumab (AMB), a CD52 monoclonal antibody, in pediatric heart transplant (HT) patients (pt).Methods: Retrospective chart review of…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 64
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences